Asian Journal of Pharmaceutical Research

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Bioavailability study of Kankasava


Affiliations
1 SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur (CG) 495 007
     

   Subscribe/Renew Journal


Bioavailability was assessed by determining the maximum (peak) plasma drug concentration of kankasava. Blank plasma gave no interfering peak at the retention time of piperine making the analysis very simple. In the plasma concentration - time profile of kankasava formulation in rats (n=6) piperine could be detected in plasma from 0.5 to 8 hours after administration with maximum plasma concentration (2.80 - 1.76 μg/ml) at 0.5 - 1 h post dosing.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Bajad S, Bedi K L, Singh A K and Johri R K. Planta Med, 2001, 67; 176.

  • Bajad S, Coumer M, Khajuria R, Suri OP and Bedi KL. Characterization of new urinary metabolites of piperine by LC/NMR/MS studies, European J Pharmaceutical Sciences, 2003, (19(5); 413-421.

  • EMEA–The European Agency for the Evaluation of Medicinal Products–Evaluation of Medicine for Human Use, London, 2001.

  • Guidance for Industry: Bioavailability and bioequivalence studies for orally administered drug products-General considerations, U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2002.

  • Zhixiu L, Hoult J R S, Benett DC and Raman A. Planta Med, 1999, 65: 600.


Abstract Views: 871

PDF Views: 1




  • Bioavailability study of Kankasava

Abstract Views: 871  |  PDF Views: 1

Authors

Bharti Ahirwar
SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya, Bilaspur (CG) 495 007

Abstract


Bioavailability was assessed by determining the maximum (peak) plasma drug concentration of kankasava. Blank plasma gave no interfering peak at the retention time of piperine making the analysis very simple. In the plasma concentration - time profile of kankasava formulation in rats (n=6) piperine could be detected in plasma from 0.5 to 8 hours after administration with maximum plasma concentration (2.80 - 1.76 μg/ml) at 0.5 - 1 h post dosing.

References